Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients
Cameron Mura, Saskia Preißner, Susanne Nahles, Max Heiland, Philip E. Bourne, Robert Preißner
Topics & Concepts
Coronavirus disease 2019 (COVID-19)AspirinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPandemicHistamineMedicineMEDLINEPharmacologyVirologyInternal medicineBiologyBiochemistryOutbreakDiseaseInfectious disease (medical specialty)Pharmacological Receptor Mechanisms and EffectsCOVID-19 Clinical Research StudiesCancer, Stress, Anesthesia, and Immune Response